ICON PLC (ICLR)

NASDAQ
Currency in USD
147.30
+0.82(+0.56%)
Closed·
After Hours
140.50-6.80(-4.62%)
·
ICLR Scorecard
Full Analysis
Management has been aggressively buying back shares
ICLR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
145.48149.49
52 wk Range
125.10347.72
Key Statistics
Edit
Prev. Close
146.48
Open
145.75
Day's Range
145.48-149.49
52 wk Range
125.1-347.72
Volume
1.82M
Average Volume (3m)
1.54M
1-Year Change
-53.79%
Book Value / Share
117.65
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICLR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
176.87
Upside
+20.07%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

ICON PLC News & Analysis

Show more

ICON PLC Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

ICON PLC SWOT Analysis


Industry Headwinds
Explore ICON's navigation of CRO sector challenges, including study cancellations, pharma budget cuts, and shifting market dynamics
Financial Performance
Delve into ICON's recent financial results, revised guidance, and the impact of industry trends on revenue and profitability metrics
Strategic Positioning
Learn how ICON's global scale, proprietary technology, and PRA Health Sciences acquisition bolster its competitive edge in the CRO market
Future Prospects
Analyst targets range from $240 to $355, reflecting varied views on ICON's potential for margin expansion and growth amid industry uncertainties
Read full SWOT analysis

ICON PLC Earnings Call Summary for Q4/2024

  • ICON beats Q4 2024 expectations with EPS of $3.43 and revenue of $2.04B, stock rises 2.69% in premarket trading
  • Full year 2024 revenue up 2% to $8.28B, adjusted EPS rises 9.5% to $14.00, free cash flow increases 10% to $1.1B
  • Company maintains 2025 guidance despite projecting lower margins and free cash flow due to unbilled revenue
  • ICON focuses on digital innovation and automation to enhance trial completion rates and cost savings
  • Biotech market volatility and potential FDA headcount reductions pose challenges, but ICON remains optimistic about long-term growth
Last Updated: 2025-02-20, 09:28 a/m
Read Full Transcript

Compare ICLR to Peers and Sector

Metrics to compare
ICLR
Peers
Sector
Relationship
P/E Ratio
15.4x17.7x−0.5x
PEG Ratio
1.340.020.00
Price/Book
1.2x2.0x2.6x
Price / LTM Sales
1.4x1.7x3.0x
Upside (Analyst Target)
17.4%19.2%52.5%
Fair Value Upside
Unlock19.4%8.7%Unlock

Analyst Ratings

11 Buy
6 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 176.87
(+20.07% Upside)

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
3.19 / 3.18
Revenue / Forecast
2.00B / 2.03B
EPS Revisions
Last 90 days

ICLR Income Statement

People Also Watch

143.99
GTLS
+0.99%
44.320
ITX
+0.23%
201.51
EXP
+2.42%
73.25
SOLV
-0.43%
101.55
CALM
-0.54%

FAQ

What Is the ICON PLC (ICLR) Stock Price Today?

The ICON PLC stock price today is 147.30

What Stock Exchange Does ICON PLC Trade On?

ICON PLC is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for ICON PLC?

The stock symbol for ICON PLC is "ICLR."

What Is the ICON PLC Market Cap?

As of today, ICON PLC market cap is 11.71B.

What Is ICON PLC's Earnings Per Share (TTM)?

The ICON PLC EPS (TTM) is 9.25.

When Is the Next ICON PLC Earnings Date?

ICON PLC will release its next earnings report on Jul 23, 2025.

From a Technical Analysis Perspective, Is ICLR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ICON PLC Stock Split?

ICON PLC has split 2 times.

How Many Employees Does ICON PLC Have?

ICON PLC has 41250 employees.

What is the current trading status of ICON PLC (ICLR)?

As of Jun 24, 2025, ICON PLC (ICLR) is trading at a price of 147.30, with a previous close of 146.48. The stock has fluctuated within a day range of 145.48 to 149.49, while its 52-week range spans from 125.10 to 347.72.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.